![]() DermBiont DermBiont develops skin microbiome therapeutics platform to treat and prevent skin diseases. | ![]() Nouscom Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
| |
Founding Date | Founding Date 2017 | Founding Date 2015 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Boston, US HQ Emeryville, US | Locations Basel, CH HQ Roma, IT |
Employees | Employees 215% decrease | Employees 633% increase |
Funding | ||
Latest funding round | Latest funding round $ 8m (almost 7 years ago) | Latest funding round $ 49m (over 8 years ago) |
Total funding raised | Total funding raised $ 8m | Total funding raised $ 62.6m |

Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
View company